ストックスクリーナーアプリを入手
1.14
2.56%
-0.03
アフターアワーズ：
1.12
-0.02
-1.75%
Dermata Therapeutics Inc (DRMA) 最新ニュース
Dermata Therapeutics, Inc.Common Stock (NQ: DRMA - FinancialContent
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
Dermata Therapeutics Stock Price Forecast. Should You Buy DRMA? - StockInvest.us
Dermata Therapeutics Inc. Warrant (DRMAW) Peer Comparison – Compare with Others - Value Research
Dermata Therapeutics Inc. Warrant (DRMAW) Financials – Balance Sheet, Profit & Loss, Cash Flow - Value Research
Dermata Therapeutics Inc. Warrant (DRMAW) Key Financial Ratios – Valuation, Profitability & More - Value Research
Dermata Therapeutics (DRMA) Drops 8.22% to $1.34 as Selling Pressure Drags Micro-Cap Biotech LowerMAMA Signal - vinanet.vn
Dermata Therapeutics (DRMA) Slides 8.22% as Shares Press Toward Key $1.27 SupportPrice Target - dars.gov.et
Dermata launches first direct-to-consumer skincare product By Investing.com - Investing.com UK
Dermata Therapeutics Announces Commercial Launch of Tome Foundational Treatment - Yahoo Finance
Dermata (DRMA) Latest Quarter: Reported EPS Misses Expectations in the Current Update; Closing Move: Shares Move 2.90% Up for the Current SessionAnnual Report - vinanet.vn
Dermata (DRMA) Latest Quarter: Reported EPS Misses Expectations in the Current Update; Closing Move - careplusvn.com
Dermata Therapeutics (NASDAQ:DRMA) Commercial Strategy Gains Attention - kalkinemedia.com
Dermata opens preorders for Tome skincare product - Investing.com
Dermata opens preorders for Tome skincare product By Investing.com - Investing.com Canada
Dermata Announces Preorders Now Open for Tome Foundational Treatment Ahead of Commercial Launch - Newswire.com
Dermata (DRMA) Results Check: EPS Comes in Below Forecast in the Latest Reading; Market Response: Shares Move 2.80% Up for the Current SessionStrong Earnings Momentum - vinanet.vn
Dermata (NASDAQ: DRMA) ends Nasdaq listing for warrants - Stock Titan
Dermata Therapeutics raises $3.4 million in private placement - Investing.com
Dermata Therapeutics Announces Private Placement to Fund DTC Pivot - TipRanks
Form 8K Dermata Therapeutics Inc For: 17 August By Investing.com - Investing.com South Africa
Dermata Therapeutics raises $3.4 million in private placement By Investing.com - Investing.com Canada
Dermata Therapeutics Announces $3.4 Million Private Placement Priced At-The-Market Under Nasdaq Rules - ACCESS Newswire
Dermata Therapeutics Raises $3.2 Million in Private Placement; Investors Get Resale Rights - TradingView
Dermata Therapeutics, Inc. announced that it expects to receive $3.347307 million in funding - marketscreener.com
DRMA Q2 2026 Earnings: Wider-Than-Expected Loss Despite 13.8% Share Price AdvanceGross Profit Margin - vinanet.vn
Why CoreWeave Shares Are Trading Higher By Over 17%; Here Are 20 Stocks Moving Premarket - Sahm
DRMA|Dermata Therapeutics Inc|Price:1.370|Chg%:+0.290 - TradingKey
Dermata Therapeutics Stock Surges 27% Pre-Market: Why is it Moving? - webull.com
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
Unusual volume stocks are being observed in Wednesday's session. - ChartMill
The market is filled with gapping stocks in Wednesday's session. - ChartMill
DRMA Stock In Focus As Dermata Pivots To Direct-To-Consumer Skincare - timothysykes.com
DRMA Stock Draws Traders As Dermata Pivots To Skincare - StocksToTrade
Went from a daytrader to a swing trader just like that... - Moomoo
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
DRMA Stock Draws Traders As Dermata Pivots To Skincare Launch - StocksToTrade
DERMATA THERAPEUTICS ($DRMA) Releases Q2 2026 Earnings, Stock Rises - Quiver Quantitative
Dermata Therapeutics Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Trending Stocks Today | Dermata Therapeutics Soars 35.18% Post-Market - Moomoo
Dermata Therapeutics Provides Corporate Update and Reports Financial Results for the Second Quarter 2026 - ACCESS Newswire
DRMA Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Dermata Therapeutics (DRMA) faces going concern warning amid higher losses and cash burn - Stock Titan
Dermata's Tome Skincare Product Is Designed for Once-Weekly Use - Stock Titan
Dermata Therapeutics Inc expected to post a loss of 55 cents a shareEarnings Preview - TradingView
Dermata Therapeutics Inc (NASDAQ: DRMA) Share Price, DRMA Stock News, DRMA Share Price & Updates - kalkine.com.au
Dermata Therapeutics Announces Commercial Launch Date for Tome(TM) Foundational Treatment - webull.com
Dermata Therapeutics Launches Tome Foundational Skincare Line - TipRanks
Dermata to launch first consumer skincare product Aug. 25 - Investing.com
Dermata to launch first consumer skincare product Aug. 25 By Investing.com - Investing.com South Africa
3.06%
2.55%
大文字化:
|
ボリューム (24 時間):